BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24489618)

  • 1. Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer.
    Peng J; Zhu J; Bergamaschi A; Han W; Noh DY; Pollack JR; Wang P
    Ann Appl Stat; 2010 Mar; 4(1):53-77. PubMed ID: 24489618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate Boosting for Integrative Analysis of High-Dimensional Cancer Genomic Data.
    Xiong L; Kuan PF; Tian J; Keles S; Wang S
    Cancer Inform; 2015; 13(Suppl 7):123-31. PubMed ID: 26609213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparse multivariate factor analysis regression models and its applications to integrative genomics analysis.
    Zhou Y; Wang P; Wang X; Zhu J; Song PX
    Genet Epidemiol; 2017 Jan; 41(1):70-80. PubMed ID: 27862229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regularized multivariate regression approach for eQTL analysis.
    Wang X; Qin L; Zhang H; Zhang Y; Hsu L; Wang P
    Stat Biosci; 2015 May; 7(1):129-146. PubMed ID: 26085849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Proteo-genomic Analysis to Construct CNA-protein Regulatory Map in Breast and Ovarian Tumors.
    Ma W; Chen LS; Özbek U; Han SW; Lin C; Paulovich AG; Zhong H; Wang P
    Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S66-S81. PubMed ID: 31281117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of gene expression and copy number alterations using canonical correlation analysis.
    Soneson C; Lilljebjörn H; Fioretos T; Fontes M
    BMC Bioinformatics; 2010 Apr; 11():191. PubMed ID: 20398334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regularization Methods for High-Dimensional Instrumental Variables Regression With an Application to Genetical Genomics.
    Lin W; Feng R; Li H
    J Am Stat Assoc; 2015; 110(509):270-288. PubMed ID: 26392642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing functional consequences of DNA copy number alterations in breast and ovarian tumors by spaceMap.
    Conley CJ; Ozbek U; Wang P; Peng J
    J Genet Genomics; 2018 Jul; 45(7):361-371. PubMed ID: 30057342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NETWORK-REGULARIZED HIGH-DIMENSIONAL COX REGRESSION FOR ANALYSIS OF GENOMIC DATA.
    Sun H; Lin W; Feng R; Li H
    Stat Sin; 2014 Jul; 24(3):1433-1459. PubMed ID: 26316678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes.
    Yuan Y; Curtis C; Caldas C; Markowetz F
    IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(4):947-54. PubMed ID: 21788678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regularized estimation in sparse high-dimensional multivariate regression, with application to a DNA methylation study.
    Zhang H; Zheng Y; Yoon G; Zhang Z; Gao T; Joyce B; Zhang W; Schwartz J; Vokonas P; Colicino E; Baccarelli A; Hou L; Liu L
    Stat Appl Genet Mol Biol; 2017 Jul; 16(3):159-171. PubMed ID: 28734115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
    Park H; Niida A; Imoto S; Miyano S
    J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis.
    Abdel-Fatah TMA; Agarwal D; Liu DX; Russell R; Rueda OM; Liu K; Xu B; Moseley PM; Green AR; Pockley AG; Rees RC; Caldas C; Ellis IO; Ball GR; Chan SYT
    Lancet Oncol; 2016 Jul; 17(7):1004-1018. PubMed ID: 27312051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penalized differential pathway analysis of integrative oncogenomics studies.
    van Wieringen WN; van de Wiel MA
    Stat Appl Genet Mol Biol; 2014 Apr; 13(2):141-58. PubMed ID: 24552967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
    Tanioka M; Fan C; Parker JS; Hoadley KA; Hu Z; Li Y; Hyslop TM; Pitcher BN; Soloway MG; Spears PA; Henry LN; Tolaney S; Dang CT; Krop IE; Harris LN; Berry DA; Mardis ER; Winer EP; Hudis CA; Carey LA; Perou CM
    Clin Cancer Res; 2018 Nov; 24(21):5292-5304. PubMed ID: 30037817
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
    Singh A; Goel N; Yogita
    Interdiscip Sci; 2020 Mar; 12(1):12-23. PubMed ID: 31392539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.
    Aure MR; Steinfeld I; Baumbusch LO; Liestøl K; Lipson D; Nyberg S; Naume B; Sahlberg KK; Kristensen VN; Børresen-Dale AL; Lingjærde OC; Yakhini Z
    PLoS One; 2013; 8(1):e53014. PubMed ID: 23382830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparse multiple co-Inertia analysis with application to integrative analysis of multi -Omics data.
    Min EJ; Long Q
    BMC Bioinformatics; 2020 Apr; 21(1):141. PubMed ID: 32293260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.